Ginlix AI
50% OFF

Unable to Locate QHSLab, Inc.'s (USAQ) 2024 January 2 Form 8-K Filing

#8-k_form #usaq #qhslab #medical_device #sec_disclosure #financial_data
Neutral
US Stock
January 3, 2026

Unlock More Features

Login to access AI-powered analysis, deep research reports and more advanced features

Unable to Locate QHSLab, Inc.'s (USAQ) 2024 January 2 Form 8-K Filing

About us: Ginlix AI is the AI Investment Copilot powered by real data, bridging advanced AI with professional financial databases to provide verifiable, truth-based answers. Please use the chat box below to ask any financial question.

Related Stocks

USAQ
--
USAQ
--

Based on my extensive search,

I cannot find the specific content of QHSLab’s Form 8-K filing dated January 2, 2024
. This could be due to one of the following reasons:

  1. No actual Form 8-K filing was made on that date
  2. The document may not be fully indexed in public databases
  3. The document may have been updated or replaced
About QHSLab Company Background

According to brokerage API data [0], the basic information of QHSLab, Inc. (ticker: USAQ) is as follows:

Company Overview:

  • Industry:
    Medical Device
  • Current Market Capitalization:
    Approximately $9.81 million
  • Current Stock Price:
    $0.87 (as of January 2, 2026 data)

Financial Performance:

  • Net Profit Margin:
    -14.80%
  • Operating Margin:
    6.46%
  • Return on Equity (ROE):
    63.03%
  • Current Ratio:
    0.18

Stock Performance:

  • 1-Year Gain: +223.20%
  • 3-Year Gain: +443.75%
  • 5-Year Gain: +85.11%
General Purpose of Form 8-K

Form 8-K is a report used by U.S. public companies to disclose material events, usually including the following types of material events [1]:

Common Disclosure Items:

  1. Item 1.01
    - Entry into a Material Definitive Agreement
  2. Item 2.01
    - Completion of Acquisition or Disposition of Assets
  3. Item 3.01
    - Notice of Delisting or Failure to Satisfy Continued Listing Rules
  4. Item 4.01
    - Change in Accountants
  5. Item 5.02
    - Appointment or Departure of Directors or Principal Officers
  6. Item 5.07
    - Submission of Matters to a Vote of Security Holders
  7. Item 7.01
    - Regulation FD Disclosure
  8. Item 8.01
    - Other Events
  9. Item 9.01
    - Financial Statements and Exhibits
Recommendations

If you need to confirm whether QHSLab actually filed a Form 8-K on January 2, 2024 and its specific content, we recommend you:

  1. Visit the SEC Edgar Database Directly
    - Search QHSLab’s official filing history
  2. Visit the OTC Markets Website
    - View the complete list of USAQ’s filings
  3. Contact QHSLab’s Investor Relations Department
    - Obtain accurate disclosure records
References

[0] Jinling API Data - QHSLab, Inc. Company Overview and Financial Data
[1] Latham & Watkins LLP - “DESKTOP REFERENCE: FORM 8-K FILING EVENTS” (https://www.lw.com/admin/upload/SiteAttachments/Desktop-Reference-8-K-Filing-Events-2024-Latham-Watkins.pdf)


Note:
Since the specific content of the Form 8-K dated January 2, 2024 cannot be found, I cannot provide the specific details of the material event and the analysis of its actual impact on investors. If you need to analyze a specific Form 8-K document, please provide an access link or more detailed information.

Ask based on this news for deep analysis...
Alpha Deep Research
Auto Accept Plan

Insights are generated using AI models and historical data for informational purposes only. They do not constitute investment advice or recommendations. Past performance is not indicative of future results.